CHICAGO, Oct. 23, 2017 -- Mattersight Corporation (Nasdaq:MATR) today announced that it intends to release its third quarter 2017 financial results after the market close on Tuesday, November 7, 2017. Mattersight management also plans to host a conference call at 5:00 p.m. Eastern Time on Tuesday, November 7, 2017.
The conference call and slide presentation will be available at the Investor Relations section of Mattersight's website at http://www.mattersight.com/about-us/investor-relations/. To listen to the conference call via telephone, please call 800.952.4789 (domestic) or 404.665.9579 (international), conference ID: 7599929.
For those who cannot access the live broadcast, a replay of the conference call will be available beginning approximately two hours after the live call is completed until December 7, 2017, by dialing 855.859.2056 (domestic) or 404.537.3406 (international), conference ID: 7599929.
About Mattersight
Mattersight unleashes the power of personality to improve every interaction with every customer every time. With tools to learn, analyze, and predict customer behavior based on customer conversations, Mattersight helps brands create chemistry with their customers through shorter, more satisfying conversations that increase loyalty. To learn how Mattersight can help you click better with your customers visit www.mattersight.com.


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 



